Thermo Fisher Scientific Inc

0R0H.L | Healthcare | LSE
$556.19
-12.72 (-2.24%)

Key Metrics

Market Cap
$210.02B
P/E Ratio
28.99
EPS
$19.19
Beta
N/A
Dividend Yield
N/A
ROE
13.11%
Current Ratio
1.50

Company Information

Industry
Medical Pharmaceuticals

About Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc offers life sciences solutions analytical instruments specialty diagnostics and laboratory products and service worldwide The companys Life Sciences Solutions segment offers reagents instruments and consumables for biological and medical research discovery and production of drugs and vaccines as well as diagnosis of infections and diseases to pharmaceutical biotechnology agricultural clinical healthcare academic and government markets Its Analytical Instruments segment provides instruments consumables software and services for use in laboratory on production line and in field for pharmaceutical biotechnology academic government environmental and other research and industrial markets as well as clinical laboratories The companys Specialty Diagnostics segment offers liquid readytouse and lyophilized immunodiagnostic reagent kits as well as calibrators controls and calibration verification fluids ImmunoCAP for allergy and asthma tests and EliA for autoimmunity tests dehydrated and prepared culture media collection and transport systems instrumentation and consumables human leukocyte antigen typing and testing for organ transplant market and healthcare products Its Laboratory Products and Services segment provides laboratory refrigerators and freezers ultralowtemperature freezers and cryopreservation storage tanks temperature control sample preparation and preservation centrifugation and biological safety cabinet products water analysis instruments laboratory plastics products laboratory chemicals and pharma services The company offers products and services through a direct sales force customerservice professionals electronic commerce thirdparty distributors and catalogs It has a strategic alliance with the University of California San Francisco The company was incorporated in 1956 and is based in Waltham Massachusetts

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-10-22 $5.79 $5.50 +5.3%
2025-07-23 $5.36 $5.23 +2.5%
2025-04-23 $4.00 $5.10 -21.6%
2025-01-30 $6.10 $5.94 +2.7%

Financial Ratios (TTM)

Gross Margin
39.81%
Operating Margin
18.22%
Net Margin
15.02%
ROA
6.38%
Price to Book
4.20
Price to Sales
4.90